Testing for alpha-1 antitrypsin deficiency and cystic fibrosis was negative, prompting genetic testing, which revealed the PLCG2 Met1141Lys variant of uncertain significance. This evidence concerns the gene PLCG2 and hyperinsulinemic hypoglycemia, familial, 4.